Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Allergy
Open-data reference.
16 US clinical trials · 3 currently recruiting
Active & Recent Trials
Understanding Allergies and Sensitizations in Healthy and Allergic Individuals
Stanford University
NCT04828603
Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)
DBV Technologies
NCT07003919
The Nonirritating Concentrations of Midazolam, Ketamine, and Ondansetron
Mayo Clinic
NCT07103720
Childhood Allergy and the Neonatal Environment
University of Wisconsin, Madison
NCT04215783
Urban Environmental Factors and Childhood Asthma
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00114881
Vitamin D, Steroids, and Asthma in African American Youth
Robert J. Freishtat
NCT01647399
Neuromuscular Blocking Agents Utilized During Perioperative Hypersensitivity Evaluation
Mayo Clinic
NCT04046731
Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00078195
The Leaky Lung Test
University of Rochester
NCT02306473
Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus
Illinois College of Optometry
NCT04418999
Sublingual Cockroach Safety in Adults With Cockroach Allergy & Perennial Allergic Rhinitis With or Without Asthma
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00434421
In Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic Asthmatics
University of North Carolina, Chapel Hill
NCT00836368
Single Ascending-dose Study of the Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic, Adult Subjects
Regeneron Pharmaceuticals
NCT01922661
Evaluating for Contact Allergies in Patients With Chronic Urticaria
Tufts Medical Center
NCT00868036
Roflumilast In-Vitro Basophil Release
Creighton University
NCT00613587
Advanced Multimodal Wireless Vital Signs Monitoring for Patients With Asthma and Anaphylaxis
Northwestern University
NCT04360213
Phase Distribution
| Phase | Trial count |
|---|---|
| Early Phase 1 | 5 |
| Phase 2 | 1 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Allergy Trial Landscape
ClinicalTrials.gov lists 16 US studies indexed under Allergy, and 3 of those are currently open to recruitment — roughly 19% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Allergy shows 2 late-stage studies (Phase 3 and Phase 4 combined) alongside 6 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Allergy is led by National Institute of Allergy and Infectious Diseases (NIAID) with 3 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 16 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Allergy?
PlainTrial tracks 16 US clinical trials for Allergy, of which 3 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Allergy?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.